CME vs MSCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CME

37.7
AI Score
VS
MSCI Wins

MSCI

57.7
AI Score

Investment Advisor Scores

CME

38score
Recommendation
SELL

MSCI

58score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CME MSCI Winner
Forward P/E 21.7865 29.3255 CME
PEG Ratio 4.68 2.2155 MSCI
Revenue Growth 0.8% 12.2% MSCI
Earnings Growth 2.5% 19.6% MSCI
Tradestie Score 37.7/100 57.7/100 MSCI
Profit Margin 63.4% 40.7% CME
Beta 1.00 1.00 Tie
AI Recommendation SELL STRONG BUY MSCI

Relative Price Performance (Last 90 Days)

CME 1M: +8.1% · 3M: -4.9% MSCI 1M: +2.0% · 3M: -3.2%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $274.98

MSCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.5 · Price: $563.49

Fundamentals Snapshot

Metric CME MSCI
Market Cap
Forward P/E 21.3 25.1
Trailing P/E 22.6 31.1
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.8%
Operating Margin 0.7% 0.6%
EPS 11.97 18.31
Dividend Yield 0.02% 0.01%

Frequently Asked Questions

Based on our detailed analysis, MSCI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.